Neuronetics major shareholder buys additional shares

Got story updates? Submit your updates here. ›

Neuronetics, Inc. (NASDAQ:STIM) major shareholder Jorey Chernett purchased 169,472 additional shares of the company's stock in a series of transactions from March 17-20, 2026. The purchases increased Chernett's total stake in Neuronetics to over 8.7 million shares, or approximately 10% of the company.

Why it matters

Insider buying activity can be a signal of confidence in a company's future prospects. Chernett's substantial purchases suggest the major shareholder believes Neuronetics is undervalued and has potential for growth, despite the company's recent stock price declines.

The details

Chernett acquired the shares at an average price ranging from $1.16 to $1.41 per share, for a total transaction value of over $1.2 million. The purchases represented a 1.98% increase in Chernett's existing position. Neuronetics develops and markets non-invasive neuromodulation therapies, with its flagship NeuroStar Advanced Therapy System used to treat major depressive disorder.

• On Tuesday, March 17, 2026, Chernett bought 531,000 shares at an average price of $1.16 per share.
• On Wednesday, March 18, 2026, Chernett acquired 607,400 shares at an average price of $1.35 per share.
• On Thursday, March 19, 2026, Chernett purchased 450,000 shares at an average price of $1.33 per share.
• On Friday, March 20, 2026, Chernett bought an additional 169,472 shares at an average price of $1.41 per share.